Nk-1 receptor antagonist, 5-ht3 receptor antagonist and dexamethasone antiemetic regimen to prevent nausea and vomiting induced by chemotherapy drugs with high emetic risk for several days

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2019
This article has no abstract
Epistemonikos ID: d81025857044c2d13ad8e28bcfa7b6cf863fe60c
First added on: Apr 07, 2025